CHRONOSENSE
DEAD

Serial Number

98646751

Owner

DeepSense Biotechnologies Inc

Attorney

Johan Brag

First Use Date

Jan 1, 2024

Filing Date

Jul 12, 2024

Add to watchlist:

No watchlists yet
View on USPTO

CHRONOSENSE Trademark

Serial Number: 98646751

CHRONOSENSE is a trademark filed by DeepSense Biotechnologies Inc on July 12, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

DeepSense Biotechnologies Inc (3 trademarks)

6 Berndale drive
Westport, CT 06880

Entity Type: 03

Trademark Details

Filing Date

July 12, 2024

Registration Date

Not Registered

First Use Anywhere

January 1, 2024

First Use in Commerce

January 1, 2024

Goods & Services

Allergy relief medication; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Dietary supplements for controlling cholesterol; Dietary supplements for humans and animals; Dietary supplements in the form of tablets, capsules, powders, liquids, gels, patches, power bars, chewing gum, gummies.; Dietary supplements with a cosmetic effect; Dietary and nutritional supplements; Dietary and nutritional supplements used for weight loss; Dietary food supplements; Medicines made of Chinese traditional medicinal herbs; Plant and herb extracts, other than essential oils, sold as an integral component of medicated cosmetics; Plant and herb extracts, other than essential oils, for medicinal purposes; Prebiotic supplements; Flavonoids for use as a dietary supplement; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Medicinal creams for skin care; Nasal drops for the treatment of allergies; Natural dietary supplements; Natural dietary supplements for the treatment of sleep disorders, mood disorders, immune system disorders, circadian clock disorders, metabolic disorders, chronic fatigue disorders, skin disorders, allergies, inflammatory disorders; Non-medicated topical gel for the prevention and treatment of allergies; Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for the treatnnt of long COVID disorders; Nutritional and dietary supplements formed and packaged as bars; Pharmaceutical preparations for skin care; Pharmaceutical preparations for treating allergies

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Apr 28, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 28, 2025 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 8, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jan 8, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jan 8, 2025 CNRT
ASSIGNED TO EXAMINER
Dec 31, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 12, 2024 NWOS
NEW APPLICATION ENTERED
Jul 12, 2024 NWAP